Eastern

LEAD PLAINTIFF DEADLINE IS JULY 25, 2022 NEW YORK, June 9, 2022 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against Spero Therapeutics, Inc.…

LEAD PLAINTIFF DEADLINE IS JUNE 14, 2022 NEW YORK, May 2, 2022 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against Aurinia Pharmaceuticals…

LEAD PLAINTIFF DEADLINE IS MAY 13, 2022 NEW YORK, March 24, 2022 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed against Akebia Therapeutics, Inc.…

FREE TIME FOR APPLICANTS IS JULY 13, 2021NEW YORK, July 1, 2021 / PRNewswire / - Wolf Haldenstein Adler Freeman & Herz LLP announces that a state securities class action has been filed in The United States District Court of Eastern…

NEW YORK, March 26, 2021 / PRNewswire / - Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed in the US District Court for the Eastern District of new York on behalf of buyers of investment…

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) - Wolf Haldenstein Adler Freeman & Herz LLP announces a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of reciprocal buyers in the…